Compare Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mizuho Financial Group Inc. Sponosred ADR (Japan) vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.61 (market cap $127.85B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 5.1× Royalty Pharma plc Class A Ordinary Shares's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays the higher dividend (1.72%). Which is the better fit depends on your goals — on Pluang, investors hold Mizuho Financial Group Inc. Sponosred ADR (Japan) for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| MFG | RPRX | |
|---|---|---|
Market Cap | $127.85B | $25.27B |
Volume | 3,950,750 | 3,671,183 |
Sector | Financials | Health |
52-Week High | $11.45 | $63.96 |
52-Week Low | $6.09 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $35.14T | $32.50B |
Dividend Yield | 1.72% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mizuho Financial Group Inc. Sponosred ADR (Japan)
Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
